Utilization and costs of non-evidence-based (non-EBM) antineoplastic agents in patients with metastatic colon cancer (mCC).
J. A. de Souza
No relevant relationships to disclose
B. N. Polite
No relevant relationships to disclose
S. Zhu
No relevant relationships to disclose
J. J. Dignam
No relevant relationships to disclose
N. J. Meropol
Consultant or Advisory Role - Genentech
M. J. Ratain
Consultant or Advisory Role - Genentech; Mylan; Teva
Research Funding - Bristol-Myers Squibb
L. N. Newcomer
Employment or Leadership Position - UnitedHealth Group
Stock Ownership - UnitedHealth Group
G. C. Alexander
No relevant relationships to disclose